Sagar Agarwal

2.2k total citations
30 papers, 1.8k citations indexed

About

Sagar Agarwal is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Sagar Agarwal has authored 30 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 8 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in Sagar Agarwal's work include Drug Transport and Resistance Mechanisms (13 papers), Glioma Diagnosis and Treatment (6 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Sagar Agarwal is often cited by papers focused on Drug Transport and Resistance Mechanisms (13 papers), Glioma Diagnosis and Treatment (6 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Sagar Agarwal collaborates with scholars based in United States, New Zealand and India. Sagar Agarwal's co-authors include William F. Elmquist, Ramola Sane, John R. Ohlfest, Björn Bauer, Anika M. S. Hartz, Rajneet K. Oberoi, Jose L. Gallardo, Rajendar K. Mittapalli, Naveed Shaik and Ying Chen and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Sagar Agarwal

29 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sagar Agarwal United States	18	922	651	427	336	252	30	1.8k
Rajendar K. Mittapalli United States	27	1.3k 1.4×	943 1.4×	723 1.7×	184 0.5×	876 3.5×	59	2.8k
Georg Karpel‐Massler Germany	36	565 0.6×	1.9k 2.9×	881 2.1×	37 0.1×	260 1.0×	103	3.1k
Patricia Vrignaud France	25	945 1.0×	698 1.1×	108 0.3×	43 0.1×	305 1.2×	57	1.8k
Yongtao Wang China	22	815 0.9×	698 1.1×	389 0.9×	24 0.1×	111 0.4×	47	2.1k
Stanley Chun-Wei Lee United States	20	204 0.2×	983 1.5×	114 0.3×	55 0.2×	102 0.4×	54	1.7k
Mahmoud Toulany Germany	32	1.1k 1.2×	1.9k 3.0×	131 0.3×	102 0.3×	716 2.8×	59	3.0k
Yang Jiang China	28	379 0.4×	1.5k 2.2×	196 0.5×	37 0.1×	220 0.9×	64	2.1k
Selvi Durmuş Netherlands	16	568 0.6×	482 0.7×	87 0.2×	134 0.4×	85 0.3×	24	1.0k
Andrew Poklepovic United States	30	917 1.0×	1.5k 2.3×	120 0.3×	50 0.1×	288 1.1×	129	2.7k
Leanne C. Huysentruyt United States	16	476 0.5×	783 1.2×	101 0.2×	15 0.0×	123 0.5×	20	1.6k

Countries citing papers authored by Sagar Agarwal

Since Specialization

Citations

This map shows the geographic impact of Sagar Agarwal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sagar Agarwal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sagar Agarwal more than expected).

Fields of papers citing papers by Sagar Agarwal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sagar Agarwal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sagar Agarwal. The network helps show where Sagar Agarwal may publish in the future.

Co-authorship network of co-authors of Sagar Agarwal

This figure shows the co-authorship network connecting the top 25 collaborators of Sagar Agarwal. A scholar is included among the top collaborators of Sagar Agarwal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sagar Agarwal. Sagar Agarwal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Agarwal, Sagar, Alice McDonald, Dapeng Chen, et al.. (2025). Pharmacokinetics and Pharmacodynamics of KT‐474, a Novel Selective Interleukin‐1 Receptor–Associated Kinase 4 (IRAK4) Degrader, in Healthy Adults. Clinical and Translational Science. 18(3). e70181–e70181. 4 indexed citations

Naqash, Abdul Rafeh, Reva Schneider, Aditi Shastri, et al.. (2024). Safety, pharmacokinetics (PK), pharmacodynamics (PD) and efficacy of KT-253, a targeted protein degrader of MDM2, in patients with relapsed/refractory (R/R) solid tumors, lymphoma, high grade myeloid malignancies and acute lymphoblastic leukemia (ALL).. Journal of Clinical Oncology. 42(16_suppl). 3084–3084. 6 indexed citations

Saha, Sajal, et al.. (2023). Genoplasmics: Advancing Plant Germplasm Research through Genomics. International Journal of Plant & Soil Science. 35(21). 106–116.

Huang, Stephen A., Jörg Täubel, Giuseppe Fiore, et al.. (2020). Abstract 14387: Dose-Related Reductions in Blood Pressure With a RNA Interference (RNAi) Therapeutic Targeting Angiotensinogen in Hypertensive Patients: Interim Results From a First-In-Human Phase 1 Study of ALN-AGT01. Circulation. 142(Suppl_3). 14 indexed citations

Garg, Varun, Chonghua Li, Sagar Agarwal, et al.. (2019). Pharmacokinetic and Drug–Drug Interaction Profiles of the Combination of Tezacaftor/Ivacaftor. Clinical and Translational Science. 12(3). 267–275. 29 indexed citations

Li, Li, Sagar Agarwal, & William F. Elmquist. (2013). Brain Efflux Index To Investigate the Influence of Active Efflux on Brain Distribution of Pemetrexed and Methotrexate. Drug Metabolism and Disposition. 41(3). 659–667. 30 indexed citations

Sane, Ramola, Sagar Agarwal, Rajendar K. Mittapalli, & William F. Elmquist. (2013). Saturable Active Efflux by P-Glycoprotein and Breast Cancer Resistance Protein at the Blood-Brain Barrier Leads to Nonlinear Distribution of Elacridar to the Central Nervous System. Journal of Pharmacology and Experimental Therapeutics. 345(1). 111–124. 39 indexed citations

Agarwal, Sagar, Rajendar K. Mittapalli, Jose L. Gallardo, et al.. (2012). Active Efflux of Dasatinib from the Brain Limits Efficacy against Murine Glioblastoma: Broad Implications for the Clinical Use of Molecularly Targeted Agents. Molecular Cancer Therapeutics. 11(10). 2183–2192. 77 indexed citations

Dudek, Arkadiusz Z., Ahmad Raza, Ming Chi, et al.. (2012). Brain Metastases from Renal Cell Carcinoma in the Era of Tyrosine Kinase Inhibitors. Clinical Genitourinary Cancer. 11(2). 155–160. 39 indexed citations

10.

Wang, Tianli, Sagar Agarwal, & William F. Elmquist. (2012). Brain Distribution of Cediranib Is Limited by Active Efflux at the Blood-Brain Barrier. Journal of Pharmacology and Experimental Therapeutics. 341(2). 386–395. 33 indexed citations

11.

Sane, Ramola, Sagar Agarwal, & William F. Elmquist. (2012). Brain Distribution and Bioavailability of Elacridar after Different Routes of Administration in the Mouse. Drug Metabolism and Disposition. 40(8). 1612–1619. 49 indexed citations

12.

Agarwal, Sagar, Yasuo Uchida, Rajendar K. Mittapalli, et al.. (2012). Quantitative Proteomics of Transporter Expression in Brain Capillary Endothelial Cells Isolated from P-Glycoprotein (P-gp), Breast Cancer Resistance Protein (Bcrp), and P-gp/Bcrp Knockout Mice. Drug Metabolism and Disposition. 40(6). 1164–1169. 102 indexed citations

13.

Agarwal, Sagar, Pooja Manchanda, Michael A. Vogelbaum, John R. Ohlfest, & William F. Elmquist. (2012). Function of the Blood-Brain Barrier and Restriction of Drug Delivery to Invasive Glioma Cells: Findings in an Orthotopic Rat Xenograft Model of Glioma. Drug Metabolism and Disposition. 41(1). 33–39. 120 indexed citations

14.

Agarwal, Sagar, Ramola Sane, Rajneet K. Oberoi, John R. Ohlfest, & William F. Elmquist. (2011). Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain. Expert Reviews in Molecular Medicine. 13. e17–e17. 233 indexed citations

15.

Agarwal, Sagar, Anika M. S. Hartz, William F. Elmquist, & Björn Bauer. (2011). Breast Cancer Resistance Protein and P-Glycoprotein in Brain Cancer: Two Gatekeepers Team Up. Current Pharmaceutical Design. 17(26). 2793–2802. 212 indexed citations

16.

Agarwal, Sagar, Ramola Sane, John R. Ohlfest, & William F. Elmquist. (2010). The Role of the Breast Cancer Resistance Protein (ABCG2) in the Distribution of Sorafenib to the Brain. Journal of Pharmacology and Experimental Therapeutics. 336(1). 223–233. 131 indexed citations

17.

Agarwal, Sagar, Ramola Sane, Jose L. Gallardo, John R. Ohlfest, & William F. Elmquist. (2010). Distribution of Gefitinib to the Brain Is Limited by P-glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2)-Mediated Active Efflux. Journal of Pharmacology and Experimental Therapeutics. 334(1). 147–155. 205 indexed citations

18.

Chen, Ying, Sagar Agarwal, Naveed Shaik, et al.. (2009). P-glycoprotein and Breast Cancer Resistance Protein Influence Brain Distribution of Dasatinib. Journal of Pharmacology and Experimental Therapeutics. 330(3). 956–963. 155 indexed citations

19.

Giri, Nagdeep, Sagar Agarwal, Naveed Shaik, et al.. (2008). Substrate-Dependent Breast Cancer Resistance Protein (Bcrp1/Abcg2)-Mediated Interactions: Consideration of Multiple Binding Sites in in Vitro Assay Design. Drug Metabolism and Disposition. 37(3). 560–570. 63 indexed citations

20.

Agarwal, Sagar, et al.. (1983). In vivo distribution & action of emetine on protein synthesis in hamster tissues.. PubMed. 21(6). 353–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact